Axogen (AXGN) Return on Invested Capital (2012 - 2013)

Axogen (AXGN) posted quarterly Return on Invested Capital of 0.07% for Q2 2013, up 161.27% quarter-over-quarter from 0.11% in Q4 2012.

Axogen (AXGN) Return on Invested Capital (2012 - 2013) Analysis & Trends

Axogen's Return on Invested Capital history runs 2 years deep, the most recent figure standing at 0.07% for Q2 2013.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROIC (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn	0.01%
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn	0.01%
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn	0.01%
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn	0.00%
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn	-
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn	-
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn	0.01%
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn	0.00%
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn	0.04%
10	Axogen	2.49 Bn	2.38 Bn	50.67 Mn	-

Download Data